the specific objective of this funding opportunity is to provide support for a nationwide, coordinated effort to:

• conduct an in-depth, systematic analysis of systemic issues in perinatal health care provision at the national level;
• generate a comprehensive set of evidence-based national recommendations to address the issues identified; and
• translate those recommendations into actions at the national, regional and/or provincial level that result in demonstrable, measurable improvements in perinatal health care delivery and consequently improved maternal and infant outcomes at a national level.

ihdcyh is launching its third round of the ihdcyh talks video competition, a unique opportunity to submit short 4-5 minute videos sharing evidence-based messages in the area of maternal, reproductive, child and youth health. the ihdcyh talks video competition is an opportunity to profile research and ideas within ihdcyh’s mandate to improve knowledge translation and help demonstrate the impact that evidence can and does have on maternal, reproductive, child and youth health in canada.

the objective of this competition is to encourage the production of videos that present a clear evidence-based message to a lay audience that is designed to have a positive impact on the health of children, youth and families.

successful videos will be posted on cihr and ihdcyh social media and shared through other communications channels. it is important that the content be engaging, easily understood and accessible to a lay audience.

the specific objectives of this funding opportunity are:

• to support planning activities, partnership development and/or increasing understanding of the health research landscape that will contribute to the advancement of research consistent with the mandate of cihr; and/or;
• to support dissemination events/activities that focus on the communication of health research evidence to the appropriate researcher and/or knowledge user audience(s), tailoring the message and medium as appropriate.

the specific objectives of this funding opportunity are:

• promote the creation of new knowledge that is relevant to communities affected by hiv in canada and to the goals of the federal initiative;
• promote the dissemination of new knowledge and uptake of evidence into action to enhance the community response to the hiv/aids epidemic;
• develop partnerships between researchers and affected communities;
• build capacity in the knowledge user community to engage in research and use evidence in their everyday business; and
• build the next generation of hiv/aids cbr researchers through meaningful engagement of trainees in high quality cbr projects.
• to reduce the incidence of new infections in high risk groups by focusing research on prevention efforts.

the clinical rehabilitation new investigator award provides recipients the opportunity to develop and demonstrate their independence in initiating and conducting research in the area of rehabilitation sciences through provision of a contribution to their salary. this award is designed to provide protected time for early-career clinical investigators, including allied health professionals, to undertake clinical or translational rehabilitation research.

the fiscal year 2016 (fy16) defense appropriations act provides $120 million (m) to the department of defense breast cancer research program (bcrp) to support innovative, high-impact breast cancer research to accelerate progress toward ending breast cancer. as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, research, development, and acquisition (dha rda) directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy16 bcrp program announcements and general application instructions for the following award mechanism is posted on the grants.gov website. breakthrough award funding levels 1 and 2 will be available in late august.

applications submitted to the fy16 bcrp must address one or more of the following overarching challenges:

·         prevent breast cancer (primary prevention)

·         identify determinants of breast cancer initiation, risk, or susceptibility

·         distinguish deadly from indolent breast cancer

·         conquer the problems of overdiagnosis and overtreatment

·         identify what drives breast cancer growth; determine how to stop it

·         identify why some breast cancers become metastatic

·         determine why/how breast cancer cells lay dormant for years and then re-emerge (recurrence); determine how to prevent recurrence

·         revolutionize treatment regimens by replacing them with ones that are more effective and less toxic

·         eliminate the mortality associated with metastatic breast cancer

http://cdmrp.army.mil/funding/bcrp.shtml

breakthrough award

funding levels 3 and 4:

• independent investigators at all academic levels (or equivalent)

• supports promising research that has the potential to lead to or make breakthroughs in breast cancer.
• potential impact of the research may be near-term or long-term, but it must be significant and go beyond an incremental advancement.
• partnering principal investigator (pi) option allows two pis, termed initiating and partnering pis, to collaborate on a single application.
• it is the responsibility of the pi to select the funding level that is most appropriate for the research proposed. the funding level should be selected based on the scope of the research project, rather than the amount of the budget.
• clinical trials are allowed.
• each pi may submit only one application as a pi or initiating pi.  there are no limitations on the number of applications for which an investigator may be named as a partnering pi.  however, applicants are discouraged from submitting as a partnering pi on multiple applications unless they are clearly unique, meaningful collaborations addressing distinct research questions.
• pis must include two or more breast cancer advocates on their research team.
• submission of a preproposal is required’ application submission is by invitation only.

applications may be submitted under one of the following funding levels:

funding level 3:

• maximum funding of $2.5m in direct costs (plus indirect costs)
• maximum period of performance is 4 years

funding level 3 - partnering pi option:

• maximum funding of $4m for direct costs (plus indirect costs)
• maximum period of performance is 4 years

funding level 4 - partnering pi option:

• maximum funding of $10m for direct costs (plus indirect costs)
• maximum period of performance is 4 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions are available for electronic downloading from the grants.gov website. the application package containing the required forms for each award mechanism can be found on grants.gov. a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420.

applications must be submitted through the federal government's single-entry portal, grants.gov. for email notification when program announcements are released go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications. for more information about the bcrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

research project grant objective

the fiscal year 2016 (fy16) defense appropriations act provides $7.5 million (m) to the department of defense epilepsy research program (erp).  the erp supports research that will explore the causative links between tbi and epilepsy, with the hope that one day post-traumatic epilepsy will be preventable.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, research, development, and acquisition (dha rda) directorate manages and executes the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

the fy16 erp program announcement and general application instructions for the following award mechanism is posted on the grants.gov website

http://cdmrp.army.mil/funding/erp.shtml

fy16 erp focus areas:

all applications for the fy16 erp funding opportunities must address at least one of the following fy16 focus areas.  an application that proposes research outside of these fy16 focus areas is acceptable, as long as the applicant provides a strong rationale as to the relevance of the research to the erp’s mission.

the erp fy16 focus areas are as follows:

epidemiology:  epidemiological characterization of post traumatic epilepsy (pte) following tbi, which may include:

·         risk factors such as demographics, genetic factors, organic head injury factors, or type of insult

·         differentiation of pte and psychogenic non-epileptic seizures (pnes)

·         outcomes including latency to epilepsy, morbidities and comorbidities, and mortality

·         pre-existing conditions including psychological and psychiatric risk factors

markers and mechanisms:  identifying markers or mechanisms (via clinical or preclinical models) that address pte:

·         early detection

·         diagnosis

·         prognosis

·         comorbidity

·         mortality

·         risk stratification

models of pte:  development of new models or better characterization of existing etiologically relevant models for pte, including repetitive tbi.

psychogenic non-epileptic seizures:  exploration of the epidemiology, mechanisms, risk factors, or markers of pnes subsequent to tbi.  research on non-pharmacological interventions in this population is also encouraged.

the fy16 erp will offer the idea development award. this award mechanism will offer two levels of research funding.

idea development award – preapplication due august 17, 2016

for either level i or ii, the pi must be an independent investigator at or above the level of assistant professor (or equivalent).

supports research to understand the magnitude and underlying mechanisms of post-traumatic epilepsy, especially in service members and veterans while benefiting the civilian community

level i:  supports investigator-initiated research that may be high-risk and/or high-gain.

level ii: supports advanced studies that may be multidisciplinary in nature, and/or have multiple collaborators.

applications should provide relevant preliminary data to support the application’s research hypothesis (or hypotheses).

preproposal submission is required; application submission is by invitation only.

level i:

·         funding limit is $500,000 direct costs.

·         maximum period of performance is 3 years.

·         indirect costs may be proposed in accordance with the institution's rate agreement.

level ii:

·         funding limit is $3.7m total (direct and indirect) costs.

·         maximum period of performance is 4 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov. a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420.

applications must be submitted through the federal government's single-entry portal, grants.gov.  for email notification when program announcements are released, go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications.  for more information about the erp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

dissertation fieldwork grants are awarded to aid doctoral or thesis research. the program contributes to the foundation's overall mission to support basic research in anthropology and to ensure that the discipline continues to be a source of vibrant and significant work that furthers our understanding of humanity's cultural and biological origins, development, and variation. the foundation supports research that demonstrates a clear link to anthropological theory and debates, and promises to make a solid contribution to advancing these ideas. there is no preference for any methodology, research location, or subfield. the foundation particularly welcomes proposals that employ a comparative perspective, can generate innovative approaches or ideas, and/or integrate two or more subfields.

post-ph.d. research grants are awarded to individuals holding a ph.d. or equivalent degree to support individual research projects. the program contributes to the foundation's overall mission to support basic research in anthropology and to ensure that the discipline continues to be a source of vibrant and significant work that furthers our understanding of humanity's cultural and biological origins, development, and variation. the foundation supports research that demonstrates a clear link to anthropological theory and debates, and promises to make a solid contribution to advancing these ideas. there is no preference for any methodology, research location, or subfield. the foundation particularly welcomes proposals that employ a comparative perspective, can generate innovative approaches or ideas, and/or integrate two or more subfields.

applications to the fiscal year 2017-2018 (fy17-18) joint program committee 8/clinical and rehabilitative medicine research program (jpc-8/crmrp) neuromusculoskeletal injuries rehabilitation research award (nmsirra) are being solicited for the defense health agency, research, development, and acquisition (dha rda) directorate, by the u.s. army medical research acquisition activity (usamraa). as directed by the office of the assistant secretary of defense for health affairs [oasd(ha)], the dha rda directorate manages and executes the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the us army medical research and materiel command (usamrmc) congressionally directed medical research programs (cdmrp) provides defense medical research and development program (dmrdp) execution management support for dhp core research program areas, including jpc-8/crmrp. this program announcement/ funding opportunity and subsequent awards will be managed and executed by cdmrp with strategic oversight from jpc-8/crmrp.

the jpc-8/crmrp is one of six major program areas within the dha rda and seeks to implement long-term strategies to develop knowledge and materiel products to reconstruct, rehabilitate, and provide definitive care for injured service members. the ultimate goal is to return service members to duty and improve their quality of life.

the neuromusculoskeletal injuries rehabilitation research award (nmsirra) programmatic panel identified the following five major focus areas for fy17-18.

to meet the intent of the award mechanism, applications must specifically address one or more of the fy17-18 jpc-8/crmrp nmsirra focus areas listed here. applications proposing research outside of these focus areas should not be submitted in response to this program announcement/funding opportunity.

·     lack of short- and long-term evidence for existing support and reintegration strategies, and a need for new evidence-based support and reintegration strategies

·     limited current technologies, including prosthetics and orthotics, for the rehabilitation or replacement of function that optimize patient interaction, usability, and durability

·     limited ability to predict, prevent, and mitigate development of secondary health deficits following neuromusculoskeletal injury

·     limited understanding of the management of patient rehabilitation strategies throughout the rehabilitation process following neuromusculoskeletal injury

·     lack of validated metrics that effectively assess initial presentation, rehabilitation, and reintegration following neuromusculoskeletal injury

it is highly encouraged that applications to the fy17-18 jpc-8/crmrp nmsirra address one or more of the following areas of emphasis:

·     validate optimal dose, timing, frequency, duration, and setting of rehabilitation techniques for service members with neuromusculoskeletal injuries

·     develop and evaluate metrics to assess initial presentation, rehabilitation, and reintegration of service members with neuromusculoskeletal injuries

·     evaluate confounds that adversely affect rehabilitation (e.g., sleep, stress, nutrition, smoking, compliance, etc.) for service members with neuromusculoskeletal injuries

·     identify biomechanical markers of the development and/or progression of secondary musculoskeletal deficits (e.g., osteoarthritis, low back pain, etc.) in service members with neuromusculoskeletal injuries

·     develop and evaluate innovative rehabilitation techniques for service members with neuromusculoskeletal injuries

·     develop and evaluate new short- and long-term evidence-based support and reintegration interventions relevant to service members with neuromusculoskeletal injuries

·     identify biomarkers (physiological or biomechanical) of the development and/or progression of early-onset comorbidities and chronic complications (e.g., obesity, cardiovascular disease, etc.) in service members with neuromusculoskeletal injuries

·     develop and evaluate technologies that allow interoperability between assistive devices, power sharing, and communication to external entities to allow for optimal performance of systems and enhanced patient outcomes for service members with neuromusculoskeletal injuries

·     develop and evaluate new devices and novel application of current devices and materials for the replacement of function following neuromusculoskeletal injury

·     develop technologies to provide sensory and proprioceptive information for service members with neuromusculoskeletal injuries

·     develop technologies for user-intent control of advanced prosthetic and orthotic components for service members with neuromusculoskeletal injuries

·     develop and evaluate prosthetic sockets that allow for optimal patient performance and satisfaction for service members with amputation

http://cdmrp.army.mil/funding/pa/16dmrdpcccrppfcra_pa.pdf

fy17-18 neuromusculoskeletal injuries rehabilitation research award (nmsirra) – preapplication due august 22, 2106

for new investigator/level 1 awards:

·     within 5 years of last training position

·     able to demonstrate the freedom to pursue independent research goals outside of a formal mentorship program or arrangement

·     can provide evidence of organizational support, such as start-up funds provided by the organization, and/or use of a technician, space, facilities, and resources

·     pis working within a laboratory team are eligible to apply for this award provided they meet the criteria above

·     graduate 世界杯2022赛程表淘汰赛 , postdoctoral fellows (at the time of award), and other formally mentored researchers are not eligible for this award

for level 2 awards:

·     independent investigators at all academic levels

·     organizations eligible to apply include national, international, for-profit, non-profit, public, and private organizations

supports preclinical research and clinical trials on the functional utility of assistive devices related to the human–device interface, secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for patients with severe extremity trauma

applications must address at least one of the published fy16 nmsirra focus areas

preproposal submission is required; application submission is by invitation only

the fy16 nmsirra offers two funding levels:

funding level 1:

 maximum funding of $600,000 total costs (direct costs plus indirect costs)

 maximum period of performance is 3 years

funding level 2:

 maximum funding of $2,500,000 total costs (direct costs plus indirect costs)

 maximum period of performance is 4 years.

 the requested budget level should be appropriate for the scope of research proposed.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  for email notification when program announcements are released go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications.  for more information about the dmrdp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org